2nd Annual

PHARMAOMICS & AI 2026

|


view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

Meet Our Featured Speakers

Loganathan Kumarasamy

Loganathan Kumarasamy

Zifo

Close icon
Ricardo Bastos

Ricardo Bastos

ONI

Loganathan Kumarasamy

Loganathan Kumarasamy

Zifo

Heather Bowling

Heather Bowling

Epistemic AI

THE PREMIER FORUM FOR AI AND OMICS-DRIVEN APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY

Welcome to PHARMA OMICS & AI 2026, an event that brings together industry leaders to explore how AI, ML, and multi-omics are transforming drug discovery, development, and real-world evidence.

The industry faces challenges such as biased and siloed data, limited scalability in multi-omics integration, and regulatory uncertainty. However, clearer methodologies and stronger data standards can drive faster therapy development, expand precision medicine, and reduce R&D costs.

Join us to gain practical insights, exchange ideas with peers, and help advance safe, effective, data-driven innovations across the pharmaceutical landscape.

key topics for

Emerging AI-driven solutions to overcome bioprocessing challenges

Learn how AI deployment in bioprocessing with PAT and digital twins reduces errors, supports predictive maintenance, and accelerates compliant batch release.

Advances in bioinformatics and omics for precision medicine and biomarkers

See how single-cell and spatial bioinformatics uncover disease pathways, reveal biomarkers, enable smarter trials, and inform treatment decisions.

Case studies highlighting data platforms for discovery and development

Explore innovative data platforms that break silos, streamline access, and add built-in checks to accelerate reliable AI and smarter decision-making in pharma.

Applying AI and ML to accelerate drug discovery, design, and development

Discover AI and ML across end-to-end R&D, from identifying targets and designing molecules to choosing sites, forecasting enrollment, and optimizing protocols.

Strategies to integrate multi-omics and patient-level data at scale

Find solutions to multi-omics integration challenges and link genomics, proteomics, and metabolomics with clinical data to deliver precision therapies at scale.

Upcoming AI regulations and safety standards across the Pharma lifecycle

Navigate FDA and EMA expectations for AI across the pharma lifecycle while building compliant, GxP-ready systems and pipelines for reliable implementation.

0

INDUSTRY TOPICS

0

NETWORKING EVENTS

0

LEADING EXPERTS

0

Q&A SESSIONS

Latest News

  • TECHNOLOGY

    1 Apr 2026

    Sanofi, Pfizer Back $787M AI Biotech Raise
  • RESEARCH

    27 Mar 2026

    Got a Billion Cells? Illumina Does
  • PARTNERSHIPS

    24 Mar 2026

    The Antibody Grind Has an AI Fix Now
  • TECHNOLOGY

    18 Mar 2026

    Bioprocessing Gets Smarter With PatroLab

Inside the Effort to Turn Tumors Into Data

Scientist inserting tissue sample cartridge into laboratory analyzer

RESEARCH

13 Mar 2026

Spatial biology and AI are turning archived tumour samples into rich datasets for cancer research

they've attended our events

Image 1Image 2
Image 1Image 2
Image 1Image 2
Image 1Image 2

Expert Speakers

Hongfeng Deng

Sanofi

Brett Hill

Arcturus Therapeutics

Daniel Dixon

TriLink BioTechnologies

Show more Speakers

Past Attendees

Sanofi

Hongene Biotech

TriLink BioTechnologies

Arranta Bio Holdings LLC

Aldevron

Orna Therapeutics

CATUG Biotechnology

DNA Script

Helix Biotech

Show more Attendees

hidden text

subscribe for updates

hidden text

our sponsors

arrow icon
4BasebioBIA SeparationsEclipseCATUG
arrow icon

related events in the series